This document provides information about the drug digoxin, including its brand name (Lanoxin), generic name, dosage, classification, mechanism of action, potential adverse reactions, and nursing considerations. Digoxin is an antidysrhythmic and inotropic agent that works by inhibiting the sodium-potassium ATPase pump in cardiac myocytes. Adverse reactions include weakness, mood changes, vision changes, and enlarged breasts in men. Nurses should monitor blood pressure, ECG, and the IV site when administering digoxin and notify healthcare providers of any new arrhythmias or bradycardia.
This document provides information about the drug digoxin, including its brand name (Lanoxin), generic name, dosage, classification, mechanism of action, potential adverse reactions, and nursing considerations. Digoxin is an antidysrhythmic and inotropic agent that works by inhibiting the sodium-potassium ATPase pump in cardiac myocytes. Adverse reactions include weakness, mood changes, vision changes, and enlarged breasts in men. Nurses should monitor blood pressure, ECG, and the IV site when administering digoxin and notify healthcare providers of any new arrhythmias or bradycardia.
This document provides information about the drug digoxin, including its brand name (Lanoxin), generic name, dosage, classification, mechanism of action, potential adverse reactions, and nursing considerations. Digoxin is an antidysrhythmic and inotropic agent that works by inhibiting the sodium-potassium ATPase pump in cardiac myocytes. Adverse reactions include weakness, mood changes, vision changes, and enlarged breasts in men. Nurses should monitor blood pressure, ECG, and the IV site when administering digoxin and notify healthcare providers of any new arrhythmias or bradycardia.
This document provides information about the drug digoxin, including its brand name (Lanoxin), generic name, dosage, classification, mechanism of action, potential adverse reactions, and nursing considerations. Digoxin is an antidysrhythmic and inotropic agent that works by inhibiting the sodium-potassium ATPase pump in cardiac myocytes. Adverse reactions include weakness, mood changes, vision changes, and enlarged breasts in men. Nurses should monitor blood pressure, ECG, and the IV site when administering digoxin and notify healthcare providers of any new arrhythmias or bradycardia.
Download as DOCX, PDF, TXT or read online from Scribd
Download as docx, pdf, or txt
You are on page 1/ 2
NAME: AMIGABLE, GRANT KENNETH D.
YEAR LEVEL: BSN 3A
DRUG STUDY
DRUG DOSAGE CLASSIFICATIO MECHANISM OF ADVERSE NURSING
NAME FREQUENCY N ACTIONS REACTIONS CONSIDERATIO PREPARATION NS BRAND DOSAGE: Antidysrhythmic binds to and weakness, Monitor BP NAME: IV: 8-12 mcg/kg s, V; Inotropic inhibits the mental/mood periodically in LANOXI (0.008-0.012 Agents. sodium/potassiu changes, patients receiving N mg/kg) total m-ATPase vision IV digoxin. loading dose (sodium pump) changes (such Monitor ECG GENERI within the as blurred or during IV C FREQUENCY: plasma yellow/green administration NAME: every 4 to 8 membrane of vision), and 6 hr after DIGOXIN hours twice cardiac myocytes enlarged/tend each dose. Notify er breasts in health care PREPARATIO men. professional if N: bradycardia or Each dose should new arrhythmias be given by IV occur. Observe infusion IV site for redness or infiltration; extravasation can lead to tissue irritation and sloughing.
